Company / Net Income
Phio Pharmaceuticals Corp. Net Income History
FY2012-FY2020 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Net Income
-$8.9M
FY2020
5-year range
-$12.5M / -$7.4M
FY2016-FY2020
Trend
-21.0%
vs FY2019
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Net Income has fluctuated over the past 7 years, ranging from -$12M in FY2018 to -$89,000 in FY2013.
Based on SEC 10-K filings.
-$9M in FY2020.
Improved from -$12M to -$9M over the past 2 years.
Net Income over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2020, net income decreased 21.0% year-over-year.
- Peak net income was recorded in FY2013.
- Lowest net income in the period was in FY2018.
Company context
Key Data Points
- Altman Z-Score -0.94 (distress zone, below 1.8 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Net IncomeValue | YoY GrowthYoY |
|---|---|---|
| FY2020 | -$8.9M | -21.0% |
| FY2019 | -$7.4M | +40.9% |
| FY2018 | -$12.5M | -38.4% |
| FY2017 | -$9.0M | +12.0% |
| FY2016 | -$10.2M | -11386.5% |
| FY2013 | -$89.0K | +0.0% |
| FY2012 | -$89.0K | - |
As of FY2020 · SEC 10-K · Updated Jun 28, 2026